跳至主要内容
临床试验/NL-OMON43968
NL-OMON43968撤回不适用

Metabolic parameters in paediatric patients with autism spectrum disorders (ASD) with and without antipsychotic medication. Prevalence, incidence and riskfactors. - Metabolic parameters in paediatric patients with ASD.

GGZ Centraal (Amersfoort)0 个研究点目标入组 112 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
2 至 17(—)

入选标准

  • Paediatric patients aged between 6 and 18 years with a DSM- IV-TR diagnosis of ASD with and without an indication for treatment with antipsychotic medication. Co-medication like stimulants or SSRI*s is allowed. Patients on antipsychotic medication will start with this medication and have to be antipsychotic-naïve.

排除标准

  • History of treatment with antipsychotic medication (ASD group without antipsychotic medication)
  • Treatment with more than 1 SGA
  • Active or past eating disorder
  • Biochemical evidence of thyroid dysfunction/diabetes mellitus.
  • Pregnancy or breastfeeding

研究者

发起方
GGZ Centraal (Amersfoort)

相似试验